Wiki source code of Neuro Critical Care
Last modified by Hussein Abdallah on 2024/04/01 19:18
Show last authors
author | version | line-number | content |
---|---|---|---|
1 | {{box cssClass="floatinginfobox" title=" "}} | ||
2 | [[image:https://pulmonarypracticeassociates.com/wp-content/uploads/2018/11/CriticalCareMedicine-img.jpg||alt="Critical Care Medicine – Pulmonary Practice" height="159" width="227"]] | ||
3 | |||
4 | **Contents** | ||
5 | |||
6 | {{toc/}} | ||
7 | {{/box}} | ||
8 | |||
9 | (% class="wikigeneratedid" %) | ||
10 | [[See pharmacy orientation presentation>>https://upmchs-my.sharepoint.com/:p:/r/personal/lukeml_upmc_edu/Documents/Lukehart/Boot%20Camp/2023-2024%20Presentations/McGinnis,%20Cory.pptx?d=w7d58f2d037194c2887820ad1e4b09606&csf=1&web=1&e=DnT8Wy]] | ||
11 | |||
12 | = **NICU TRAC** = | ||
13 | |||
14 | |||
15 | |||
16 | (% style="width:691px" %) | ||
17 | |(% style="width:332px" %)((( | ||
18 | **SUMMARY STATEMENT** | ||
19 | )))|(% style="width:356px" %)((( | ||
20 | **SERVICE NOTE / MEMO ** | ||
21 | ))) | ||
22 | |(% style="width:332px" %)((( | ||
23 | Dx: | ||
24 | |||
25 | |||
26 | |||
27 | Lines: | ||
28 | |||
29 | Code: | ||
30 | |||
31 | Goals: | ||
32 | )))|(% style="width:356px" %)((( | ||
33 | Neuro exam: | ||
34 | |||
35 | |||
36 | ICU timeline 3 days: | ||
37 | |||
38 | |||
39 | Follow-ups; | ||
40 | ))) | ||
41 | |||
42 | [[image:1711448285590-966.png]] | ||
43 | |||
44 | = **Ventilation** = | ||
45 | |||
46 | (% class="box" %) | ||
47 | ((( | ||
48 | **~ What is an SBT?** | ||
49 | ))) | ||
50 | |||
51 | (% class="box" %) | ||
52 | ((( | ||
53 | **Generally speaking, the factors predicting successful extubation are: ** | ||
54 | |||
55 | 1. Passing an SBT | ||
56 | 1. [[Rapid shallow breathing test (RSBT)>>https://www.mdcalc.com/calc/3999/rapid-shallow-breathing-index-rsbi]] | ||
57 | 1. reason for intubation was reversed | ||
58 | 1. secretions are | ||
59 | 1. neck flexion strength | ||
60 | 1. GCS / strength of cough | ||
61 | |||
62 | In neuro patients, the factors are | ||
63 | |||
64 | 1. degree of secretions | ||
65 | 1. ability to swallow (raise palate) | ||
66 | 1. predicted ability to handle secretions based on anatomy of lesion (e.g. someone with a frontal lobe lesion much more promising than a cerebellar / 4th ventricular lesion) | ||
67 | ))) | ||
68 | |||
69 | (% class="wikigeneratedid" %) | ||
70 | "desynchronous with the vent" | ||
71 | |||
72 | |||
73 | (% class="wikigeneratedid" %) | ||
74 | Upload: Respiratory Therapy Ventilator Workshop (pdf) | ||
75 | |||
76 | |||
77 | |||
78 | (% style="width:691px" %) | ||
79 | |(% style="width:332px" %) |(% style="width:356px" %) | ||
80 | |(% style="width:332px" %) |(% style="width:356px" %) | ||
81 | |||
82 | = **HYPO-Natremia** = | ||
83 | |||
84 | Remember tonicity is determined by 2 x Na+ + glucose / BUN so practically speaking you think about Na+ / glucose / BUN | ||
85 | |||
86 | __Order first__: | ||
87 | |||
88 | * Random electrolytes, urine | ||
89 | * Urine osmolality | ||
90 | * Serum osmolarity (kinda useless but just get it) | ||
91 | |||
92 | (% class="table-bordered" style="width:1487px" %) | ||
93 | |(% style="width:1042px" %)**HYPO-**tonic (Serum Osm LOW)|(% style="width:232px" %)**ISO-**tonic (Serum Osm wnl)|(% style="width:210px" %)**Hyper-**tonic (Serum Osm HIGH) | ||
94 | |(% style="width:1042px" %)((( | ||
95 | most applicable practically | ||
96 | |||
97 | |||
98 | |(% style="width:87px" %) |(% style="width:307px" %)**HYPO**-volemic|(% style="width:350px" %)**EU**-volemic|(% style="width:280px" %)**HYPER**-volemic | ||
99 | |(% style="width:87px" %)physical exam|(% style="width:307px" %)((( | ||
100 | physical exam useless | ||
101 | )))|(% style="width:350px" %)((( | ||
102 | physical exam useless | ||
103 | |||
104 | path: | ||
105 | )))|(% style="width:280px" %)((( | ||
106 | physical exam can help | ||
107 | |||
108 | path: | ||
109 | ))) | ||
110 | |(% style="width:87px" %)Path|(% style="width:307px" %)ineffective intra-arterial blood volume ~-~-> RAAS ~-~-> H2O/Na+ absorption|(% style="width:350px" %) |(% style="width:280px" %) | ||
111 | |(% style="width:87px" %)Practical examples|(% style="width:307px" %) |(% style="width:350px" %)SIADH, AI, Hypothyroidism, tea and toast diet, beer potomania|(% style="width:280px" %)cirrhotic, CHF | ||
112 | |(% style="width:87px" %)Uosm|(% style="width:307px" %)HIGH|(% style="width:350px" %)HIGH|(% style="width:280px" %)HIGH | ||
113 | |(% style="width:87px" %)UNa|(% style="width:307px" %)LOW |(% style="width:350px" %)HIGH|(% style="width:280px" %)LOW | ||
114 | |(% style="width:87px" %)Treatment|(% style="width:307px" %) |(% style="width:350px" %) |(% style="width:280px" %) | ||
115 | )))|(% style="width:232px" %)very rare, not generally applicable (e.g. MM)|(% style="width:210px" %)Hyperglyemia | ||
116 | |||
117 | |||
118 | |||
119 | __**NORMAL RANGES OF RANDOM URINE LYTES**__ | ||
120 | |||
121 | * Urine osmolality: 300 – 900 mOsm/kg | ||
122 | * Urine sodium (Na+): 40 – 260 mmol/24h | ||
123 | * Urine potassium (K+): 25 – 125 mmol/24h | ||
124 | * Urine urea: 250-125 mmol/24h | ||
125 | |||
126 | (% class="wikigeneratedid" %) | ||
127 | |||
128 | |||
129 | (% class="wikigeneratedid" %) | ||
130 | **Step-up treatment of hyponatremia** | ||
131 | |||
132 | * Fluid restriction | ||
133 | * salt tabs | ||
134 | * 1.5% | ||
135 | * 3% - given as 250 cc bolus | ||
136 | * 23% - given as a 10 minute push | ||
137 | |||
138 | (% class="wikigeneratedid" %) | ||
139 | **CSW vs. SIADH** | ||
140 | |||
141 | |||
142 | (% class="wikigeneratedid" %) | ||
143 | **Risks of overcorrecting** | ||
144 | |||
145 | (% class="wikigeneratedid" %) | ||
146 | Generally a safe rate of correction is | ||
147 | |||
148 | (% class="wikigeneratedid" %) | ||
149 | "From low to high, your pons will die" (**osmotic demyelination syndrome**) | ||
150 | |||
151 | = **AKI** = | ||
152 | |||
153 | (% class="wikigeneratedid" %) | ||
154 | Calculat FENa | ||
155 | |||
156 | |Pre-renal|intrinsic | ||
157 | |FENa |FENa | ||
158 | |Treat = IVF |Treat = diuretic? | ||
159 | |||
160 | = **Generalized Convulsing Status Epilepticus** = | ||
161 | |||
162 | ~1. Determine access | ||
163 | |||
164 | __LOADING SHORT-ACTING TREATMENT TO BREAK CONVULSIONS__ | ||
165 | |||
166 | 2a. If access: **2-4 mg IV ativan** (repeat as needed w/ escalating doses until convulses STOP q5min 4, 8, 10, no limit until break, all while calling condition C if not already called) | ||
167 | |||
168 | 2b. If no access: **10mg IM versed** (repeat as needed 10mg IM q5 min also until convulses STOP) | ||
169 | |||
170 | __+/- LOADING LONG-ACTING TREATMENT TO BREAK CONVULSIONS__: //if had to give a second round of benzo in step 2, then will need to also load with ONE of these options (orange bag should be called by this point)// | ||
171 | |||
172 | (% style="width:833px" %) | ||
173 | |(% style="width:444px" %)**LONG-ACTING AED LOADS**|(% style="width:385px" %)**Reasons to Use / Not to Use** | ||
174 | |(% style="width:444px" %)3a. **Keppra 60 mg/kg (max 4.5g) **OR **brivaracetam 100mg **once |(% style="width:385px" %)Keppra General #1 choice; Brivaracetam unusual choice outside of 4F/5F (expensive to go home on) | ||
175 | |(% style="width:444px" %)3b. **Fosphenytoin 20 mg/kg **(max ~_~_~_~_)|(% style="width:385px" %)__Reason NOT to use__: will decrease GCS 1-2 points likely and cause bradycardia | ||
176 | |(% style="width:444px" %)3c. **VPA 40 mg/kg** (max ~_~_~_~__) |(% style="width:385px" %)__Reason NOT to use__: hepatic dysfunction i.e. known cirrhosis | ||
177 | |(% style="width:444px" %)3d. **Lacosamide (Vimpat) 200-400mg **once|(% style="width:385px" %)__Reason NOT to use__: bradycardia/heart block risk | ||
178 | |||
179 | If still seizing after first-load of LONG-ACTING above, then go ahead and choose another row in the table on top of it. | ||
180 | |||
181 | If still seizing after two-loads of LONG-ACTING, intubate if not already and will need cEEG / propofol / ketamine (orange bag should be long-involved by this point) | ||
182 | |||
183 | |||
184 | __NOTES until orange bag arrives__: | ||
185 | |||
186 | - Don't hold patient down, just move harmful objects out of the way | ||
187 | |||
188 | - Get suction available STAT | ||
189 | |||
190 | - Put non-rebreather on their face even while convulsing (they WILL all desat while seizing) unless they start vomiting | ||
191 | |||
192 | = [[image:https://www.uptodate.com/services/app/contents/graphic/view/NEURO/74649/TxCSEadults.gif||alt="Image" height="1018" width="1200"]] = | ||
193 | |||
194 | __LOADING SHORT-ACTING TREATMENT TO BREAK CONVULSIONS__ | ||
195 | |||
196 | 2a. If access: **2-4 mg IV ativan** (repeat as needed w/ escalating doses until convulses STOP q5min 4, 8, 10, no limit until break, all while calling condition C if not already called) | ||
197 | |||
198 | 2b. If no access: **10mg IM versed** (repeat as needed 10mg IM q5 min also until convulses STOP) | ||
199 | |||
200 | __+/- LOADING LONG-ACTING TREATMENT TO BREAK CONVULSIONS__: //if had to give a second round of benzo in step 2, then will need to also load with ONE of these options (orange bag should be called by this point)// | ||
201 | |||
202 | (% style="width:833px" %) | ||
203 | |(% style="width:444px" %)**LONG-ACTING AED LOADS**|(% style="width:385px" %)**Reasons to Use / Not to Use** | ||
204 | |(% style="width:444px" %)3a. **Keppra 60 mg/kg (max 4.5g) **OR **brivaracetam 100mg **once |(% style="width:385px" %)Keppra General #1 choice; Brivaracetam unusual choice outside of 4F/5F (expensive to go home on) | ||
205 | |(% style="width:444px" %)3b. **Fosphenytoin 20 mg/kg **(max ~_~_~_~_)|(% style="width:385px" %)__Reason NOT to use__: will decrease GCS 1-2 points likely and cause bradycardia | ||
206 | |(% style="width:444px" %)3c. **VPA 40 mg/kg** (max ~_~_~_~__) |(% style="width:385px" %)__Reason NOT to use__: hepatic dysfunction i.e. known cirrhosis | ||
207 | |(% style="width:444px" %)3d. **Lacosamide (Vimpat) 200-400mg **once|(% style="width:385px" %)__Reason NOT to use__: bradycardia/heart block risk | ||
208 | |||
209 | If still seizing after first-load of LONG-ACTING above, then go ahead and choose another row in the table on top of it. | ||
210 | |||
211 | If still seizing after two-loads of LONG-ACTING, intubate if not already and will need cEEG / propofol / ketamine (orange bag should be long-involved by this point) | ||
212 | |||
213 | |||
214 | __NOTES until orange bag arrives__: | ||
215 | |||
216 | - Don't hold patient down, just move harmful objects out of the way | ||
217 | |||
218 | - Get suction available STAT | ||
219 | |||
220 | - Put non-rebreather on their face even while convulsing (they WILL all desat while seizing) unless they start vomiting | ||
221 | |||
222 | = [[image:https://www.uptodate.com/services/app/contents/graphic/view/NEURO/74649/TxCSEadults.gif||alt="Image" height="1018" width="1200"]] = | ||
223 | |||
224 | = **Paralytic Reversal** = | ||
225 | |||
226 | |||
227 | |||
228 | (% style="width:532px" %) | ||
229 | |(% style="width:195px" %)**Paralytic**|(% style="width:333px" %)**Reversal agent (dose)** | ||
230 | |(% style="width:195px" %)ROC|(% style="width:333px" %)Suggamadex OR Neostigmine + glycopyrrolate | ||
231 | |(% style="width:195px" %)Succinylcholine|(% style="width:333px" %)No reversal, will wear off in ~~5 minutes | ||
232 | |||
233 | = **Anticoagulation and Reversal** = | ||
234 | |||
235 | // For all DOACs/Heparin especially, make sure you know last dose. // | ||
236 | |||
237 | (% style="width:995px" %) | ||
238 | |(% style="width:264px" %)**ANTICOAGULATNT**|(% style="width:432px" %)**Agent and dose**|(% style="width:297px" %)**NOTES** | ||
239 | |(% style="width:264px" %)((( | ||
240 | |||
241 | |||
242 | * **VIT K ANTAGONIST (WARFARIN)** | ||
243 | * **APIXABAN** | ||
244 | * **EDOXABAN** | ||
245 | * **RIVAROXABAN** | ||
246 | |||
247 | |||
248 | )))|(% style="width:432px" %)((( | ||
249 | **__OPTION 1a ACUTE EMERGENCIES:__ 4F-PCC (KCentra)** | ||
250 | |||
251 | //__INR based for Warfarin (if attg cares)__// | ||
252 | |||
253 | INR 2-4: **25 units/kg** | ||
254 | |||
255 | INR 4-6: **35 units/kg** | ||
256 | |||
257 | INR 6+ or head bleed: **50 units/kg** | ||
258 | |||
259 | //__DOAC / non-INR based for Warfarin (if attg doesn't care)__// | ||
260 | |||
261 | **25 units/kg for **life-threatening bleed other than ICH | ||
262 | |||
263 | **50 units/kg for **life-threatening bleed = ICH | ||
264 | |||
265 | |||
266 | |||
267 | **__OPTION 1b ACUTE EMERGENCIES:__ FFP (If K-centra is not available)** | ||
268 | |||
269 | **10-15 mL/kg FFP, ordered in units **(200-250 mL / unit, will probably have to call blood bank) | ||
270 | )))|(% style="width:297px" %)((( | ||
271 | order and call pharmacy for K-central, generally should be efficient and accessible at all times at PUH | ||
272 | |||
273 | |||
274 | |||
275 | Ignore INR for non-Warfarin (DOACs) | ||
276 | ))) | ||
277 | |(% style="width:264px" %)((( | ||
278 | * **HEPARIN** | ||
279 | * **LOVENOX ** | ||
280 | )))|(% style="width:432px" %)**Protamine **based on last dose of heparin, call pharmacy for dosing|(% style="width:297px" %)((( | ||
281 | * can theoretically reverse SQH / SQL but pretty useless, this is generally only for IV heparin / lovenox. | ||
282 | ** c/i in shellfish allergy w/ anaphylaxis | ||
283 | ))) | ||
284 | |(% style="width:264px" %)**Dabigatran (Pradaxa)**|(% style="width:432px" %)**Idaricizumab (Praxbind)** 5 grams over 10 minutes|(% style="width:297px" %)super expensive | ||
285 | |(% style="width:264px" %)**Aspirin / Clopidogrel (Plavix)**|(% style="width:432px" %)**Platelets **or **DDAVP**|(% style="width:297px" %)0.4 mcg/kg DDAVP | ||
286 | |(% style="width:264px" %)**Hemophilia A**|(% style="width:432px" %)major head bleed: **Factor 8 50 units /kg**|(% style="width:297px" %)//FYI this is still given even if no bleed in head (you will not be called about these people)// | ||
287 | |||
288 | = = | ||
289 | |||
290 | = **Vasospasm** = | ||
291 | |||
292 | * Drugs to NOT use with vasospasm | ||
293 | ** PHB deactivates nimotop | ||
294 | ** Statins & vasospasm ~_~_~_~__ | ||
295 | ** SSRI & vasospasm ~_~_~_~__ | ||
296 | * How these patients will present practically: | ||
297 | ** Spasm window is generally day 14-21 | ||
298 | |||
299 | * (% class="box errormessage" %) | ||
300 | ((( | ||
301 | |**Treatment**|**How to order**|**Notes** | ||
302 | |Milrinone| | | ||
303 | |Verapamil| | | ||
304 | ))) | ||
305 | |||
306 | = **HYPERTENSION** = | ||
307 | |||
308 | = = | ||
309 | |||
310 | (% class="box errormessage" %) | ||
311 | ((( | ||
312 | |**Treatment**|**How to order**|**Notes** | ||
313 | |Clevidipine| | | ||
314 | |Nicardipine| | | ||
315 | ))) | ||
316 | |||
317 | |||
318 | [[image:1711428823856-735.png||height="392" width="743"]] | ||
319 | |||
320 | See attached ppt. on clevipidine / nicardipine formulary review | ||
321 | |||
322 | |||
323 | (% class="box" %) | ||
324 | ((( | ||
325 | //March 2024 update: // | ||
326 | |||
327 | //System P and T has reviewed the formulary status of clevidipine and nicardipine. We have found that the current evidence does not show that clevidipine is superior to nicardipine. There is also an approximately $750k savings to be achieved by standardizing to nicardipine. As such, we will be making clevidipine non-formulary. We will be moving to a premixed formulation of nicardipine that will be stocked in the accudoses and ORs, so there is no wait to have it come up from pharmacy. // | ||
328 | |||
329 | //This has been discussed with the CTICU, CCU and Neuro ICU medical directors as well as presby neuro anesthesia leadership and they are in agreement. Shaheryar has also discussed this with Mike Lang and Brad Gross and they are on board. We wanted to make sure that you are aware as well. // | ||
330 | |||
331 | //It will likely be a few months before we have made the appropriate EHR and operational changes to go-live with this. We will make sure to notify you when we have a go-live date. Please review the deck and let us know if you have any questions. // | ||
332 | |||
333 | |||
334 | **Chenell Donadee, MD, MBA** | ||
335 | |||
336 | Senior Medical Director, UPMC ICU Service Center | ||
337 | |||
338 | Associate Director, UPMC Pharmacy Service Center | ||
339 | |||
340 | Medical Advisor, Supply Chain, UPMC | ||
341 | |||
342 | Associate Professor, Department of Critical Care Medicine | ||
343 | |||
344 | University of Pittsburgh School of Medicine | ||
345 | |||
346 | Cell: 614-893-0994 | ||
347 | ))) | ||
348 | |||
349 | |||
350 | |||
351 | |||
352 | = **IV Fluids** = | ||
353 | |||
354 | = = | ||
355 | |||
356 | TBA | ||
357 | |||
358 | = **Tube Feeds** = | ||
359 | |||
360 | Duo-tube vs. OGT tube | ||
361 | |||
362 | = **Transcranial Dopplers** = | ||
363 | |||
364 | TBA | ||
365 | |||
366 | = **Managing Elevated ICP** = | ||
367 | |||
368 | **Medications** | ||
369 | |||
370 | (% style="width:1184px" %) | ||
371 | |(% style="width:343px" %) |(% style="width:424px" %) |(% style="width:414px" %) | ||
372 | |(% style="width:343px" %)Hypertonic Saline|(% style="width:424px" %) |(% style="width:414px" %) | ||
373 | |(% style="width:343px" %)Mannitol|(% style="width:424px" %) |(% style="width:414px" %) | ||
374 | |||
375 | = **Neuro exam - stroke patients** = | ||
376 | |||
377 | Eye deviation | ||
378 | |||
379 | * Eyes deviate **ipsilateral** to ACA/MCA temporal lobe strokes (not PCA) | ||
380 | * Eyes deviate **contrlateral** to seizures | ||
381 | |||
382 | ---- | ||
383 | |||
384 | = **Storming** = | ||
385 | |||
386 | TBA | ||
387 | |||
388 | |||
389 | = = | ||
390 | |||
391 | = **Neuro-stim** = | ||
392 | |||
393 | TBA | ||
394 | |||
395 | |||
396 | = **Neuro exam - ICU / comatose** = | ||
397 | |||
398 | **Use TOF to make sure paralytics are actually reversed. ** | ||
399 | |||
400 | //How to use TOF~:// | ||
401 | |||
402 | **NPI with pupillomoeter**: | ||
403 | |||
404 | * Point of using this over just pupil size is that it's unaffected by many ICU meds and intoxicants including opioids, NMBAs, sedatives | ||
405 | * see attached pamphlet | ||
406 | |||
407 | [[image:1711426726722-829.png||height="204" width="570"]] | ||
408 | |||
409 | [[image:1711426807128-940.png||height="559" width="619"]] | ||
410 | |||
411 | [[attach:NPI pamphlet.pdf||target="_blank"]] | ||
412 | |||
413 | = **Stroke** = | ||
414 | |||
415 | __**How to interpret a CT perfusion summary**__: | ||
416 | |||
417 | red = dead brain tissue | ||
418 | |||
419 | green = penumbra | ||
420 | |||
421 | if core < 50-70 and ratio > 1.8, then thrombectomy candidate | ||
422 | |||
423 | |||
424 | __**Candidates for DHC**__ | ||
425 | |||
426 | * Generally NOT anyone over 65 (BAG) | ||
427 | * Generally NOT anyone with two territory infarct e.g. ACA and MCA is out (Hafeez) | ||
428 | |||
429 | = (% id="cke_bm_8415S" style="display:none" %)** **(%%)**ICU Sign-out Template** = | ||
430 | |||
431 | See Intern encyclopedia for general sign-out rules. The perfect sign-out from the perfect resident consists of the following. | ||
432 | |||
433 | [[image:1711425216774-578.png||height="339" width="576"]] | ||
434 | |||
435 | [[image:1711425237808-181.png||height="345" width="558"]] | ||
436 | |||
437 | [[image:1711425268356-239.png||height="277" width="522"]] |